High Point Advisor Group LLC Catalent, Inc. Transaction History

High Point Advisor Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $66,882 - $87,476	767 Added 26.48%	3,664 $400,000
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $9,716 - $12,669	89 Added 3.17%	2,897 $386,000
Q2 2021 Jul 29, 2021	BUY	$100.34 - $115.69 $67,127 - $77,396	669 Added 31.28%	2,808 $304,000
Q1 2021 Apr 12, 2021	BUY	$101.51 - $125.27 $217,129 - $267,952	2,139 New	2,139 $234,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.